Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
45
PFE Quote, Financials, Valuation and Earnings
Last price:
$25.47
Seasonality move
:
0.58%
Day range:
$25.23 - $25.55
52-week range:
$20.92 - $27.69
Dividend yield:
6.75%
P/E ratio:
14.85x
P/S ratio:
2.32x
P/B ratio:
1.56x
Volume:
34.2M
Avg. volume:
45.4M
1-year change:
-5.14%
Market cap:
$144.9B
Revenue:
$63.6B
EPS (TTM):
$1.72
Analysts' Opinion
-
Consensus RatingPfizer Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 7 Buy ratings, 15 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $28.66, Pfizer Inc. has an estimated upside of 12.47% from its current price of $25.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $23.00 representing 9.73% downside risk from its current price of $25.48.
Fair Value
-
According to the consensus of 23 analysts, Pfizer Inc. has 12.47% upside to fair value with a price target of $28.66 per share.
PFE vs. S&P 500
-
Over the past 5 trading days, Pfizer Inc. has underperformed the S&P 500 by -0.38% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Pfizer Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Pfizer Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Pfizer Inc. reported revenues of $16.7B.
Earnings Growth
-
Pfizer Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Pfizer Inc. reported earnings per share of $0.62.
Enterprise value:
191.9B
EV / Invested capital:
--
Price / LTM sales:
2.32x
EV / EBIT:
9.86x
EV / Revenue:
3.06x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
18.49x
Price / Operating cash flow:
14.02x
Enterprise value / EBITDA:
7.34x
Gross Profit (TTM):
$43.4B
Return On Assets:
4.66%
Net Income Margin (TTM):
15.67%
Return On Equity:
10.84%
Return On Invested Capital:
6.35%
Operating Margin:
33.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $69.3B | $60.4B | $62.8B | $17.7B | $16.7B | |
| Gross Profit | $37.2B | $35.5B | $43.4B | $10.8B | $11.2B | |
| Operating Income | $11.4B | $10.1B | $19.5B | $5B | $5.5B | |
| EBITDA | $17.5B | $17B | $26.2B | $6.7B | $7.2B | |
| Diluted EPS | $1.82 | $0.74 | $1.72 | $0.78 | $0.62 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.9B | $70.4B | $74B | $43.2B | $46.9B | |
| Total Assets | $179.2B | $195.4B | $215B | $219.5B | $208.7B | |
| Current Liabilities | $41.8B | $44.3B | $31.1B | $43.2B | $36.6B | |
| Total Liabilities | $103.2B | $102.5B | $117.8B | $126.9B | $115.6B | |
| Total Equity | $76B | $92.9B | $97.2B | $92.6B | $93.1B | |
| Total Debt | $38.9B | $35.2B | $63.3B | $61.7B | $61.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $12B | $11.3B | $13.1B | $6.7B | $4.6B | |
| Cash From Investing | -$25.7B | -$6.7B | $3.2B | -$2.1B | -$2.4B | |
| Cash From Financing | $15.6B | -$6.6B | -$16B | -$4.6B | -$2.5B | |
| Free Cash Flow | $8.2B | $8.2B | $10.4B | $6.1B | $4B | |
PFE
Sector
Market Cap
$144.9B
$28.1M
Price % of 52-Week High
92.02%
51.87%
Dividend Yield
6.75%
0%
Shareholder Yield
7.78%
-1.59%
1-Year Price Total Return
-5.14%
-17.31%
Beta (5-Year)
0.472
0.495
Dividend yield:
6.75%
Annualized payout:
$1.68
Payout ratio:
69.39%
Growth streak:
14 years
Technicals
8-day SMA
Buy
Level
$25.22
200-day SMA
Buy
Level
$24.46
Bollinger Bands (100)
Buy
Level
24.31 - 25.75
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$25.29
Relative Strength Index (RSI14)
Buy
Level
54.13
ADX Line
Buy
Level
12.07
Williams %R
Neutral
Level
-44.6809
50-day SMA
Buy
Level
$25.21
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Sell
Level
-4.5B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0825)
Sell
CA Score
(Annual)
Level (-0.4603)
Buy
Beneish M-Score
(Annual)
Level (-2.694)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.6781)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, PFE has received 7 Buy ratings 15 Hold ratings, and 1 Sell ratings. The PFE average analyst price target in the past 3 months is $28.66.
-
Where Will Pfizer Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Pfizer Inc. share price will rise to $28.66 per share over the next 12 months.
-
What Do Analysts Say About Pfizer Inc.?
Analysts are divided on their view about Pfizer Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pfizer Inc. is a Sell and believe this share price will drop from its current level to $23.00.
-
What Is Pfizer Inc.'s Price Target?
The price target for Pfizer Inc. over the next 1-year time period is forecast to be $28.66 according to 23 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 15 analysts rate the stock a Hold.
-
Is PFE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Pfizer Inc. is a Hold. 15 of 23 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of PFE?
You can purchase shares of Pfizer Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pfizer Inc. shares.
-
What Is The Pfizer Inc. Share Price Today?
Pfizer Inc. was last trading at $25.47 per share. This represents the most recent stock quote for Pfizer Inc.. Yesterday, Pfizer Inc. closed at $25.48 per share.
-
How To Buy Pfizer Inc. Stock Online?
In order to purchase Pfizer Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PFE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PFE
Sector
P/E ratio
14.85x
24.20x
PEG ratio
0.11x
-0.01x
P/B ratio
1.56x
1.84x
Price / LTM sales
2.32x
1.60x
Growth Metrics
PFE
Sector
Revenue growth
-5.92%
4.51%
Earnings growth
-20.96%
10.7%
Revenue (5-year growth)
9.1%
6.45%
Earnings forecast
$0.57
-$0.19
Profitability
PFE
Sector
Profitability FY 2024
$41.8B
$3.5M
Return on invested capital
6.35%
-32.3%
Return on assets
4.66%
-28.57%
Return on equity
10.84%
-38.09%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Feb
3
Balance Sheet
PFE
Sector
Total cash
$15B
$26M
Short term investments
$19.4B
$25.7M
Total assets
$213.4B
$76.4M
Long term debt
$61.7B
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
